Unknown

Dataset Information

0

Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding.


ABSTRACT: The UDP-3-O-(R-3-hydroxyacyl)-N-acetylglucosamine deacetylase LpxC is an essential enzyme of lipid A biosynthesis in Gram-negative bacteria and a promising antibiotic target. CHIR-090, the most potent LpxC inhibitor discovered to date, displays two-step time-dependent inhibition and kills a wide range of Gram-negative pathogens as effectively as ciprofloxacin or tobramycin. In this study, we report the solution structure of the LpxC-CHIR-090 complex. CHIR-090 exploits conserved features of LpxC that are critical for catalysis, including the hydrophobic passage and essential active-site residues. CHIR-090 is adjacent to, but does not occupy, the UDP-binding pocket of LpxC, suggesting that a fragment-based approach may facilitate further optimization of LpxC inhibitors. Additionally, we identified key residues in the Insert II hydrophobic passage that modulate time-dependent inhibition and CHIR-090 resistance. CHIR-090 shares a similar, although previously unrecognized, chemical scaffold with other small-molecule antibiotics such as L-161,240 targeting LpxC, and provides a template for understanding the binding mode of these inhibitors. Consistent with this model, we provide evidence that L-161,240 also occupies the hydrophobic passage.

SUBMITTER: Barb AW 

PROVIDER: S-EPMC2141794 | biostudies-literature | 2007 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding.

Barb Adam W AW   Jiang Ling L   Raetz Christian R H CR   Zhou Pei P  

Proceedings of the National Academy of Sciences of the United States of America 20071119 47


The UDP-3-O-(R-3-hydroxyacyl)-N-acetylglucosamine deacetylase LpxC is an essential enzyme of lipid A biosynthesis in Gram-negative bacteria and a promising antibiotic target. CHIR-090, the most potent LpxC inhibitor discovered to date, displays two-step time-dependent inhibition and kills a wide range of Gram-negative pathogens as effectively as ciprofloxacin or tobramycin. In this study, we report the solution structure of the LpxC-CHIR-090 complex. CHIR-090 exploits conserved features of LpxC  ...[more]

Similar Datasets

| S-EPMC3070812 | biostudies-literature
| S-EPMC2709454 | biostudies-literature
| S-EPMC5487635 | biostudies-literature
2009-10-20 | GSE18623 | GEO
| S-EPMC3022321 | biostudies-literature
| S-EPMC3837148 | biostudies-literature
| S-EPMC2742919 | biostudies-other
| S-EPMC166197 | biostudies-literature
2009-10-27 | E-GEOD-18623 | biostudies-arrayexpress
| S-EPMC3941642 | biostudies-literature